Literature DB >> 20806836

Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment.

George M Matuschak1, Andrew J Lechner.   

Abstract

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a spectrum of acute respiratory failure with diffuse, bilateral lung injury and severe hypoxemia caused by non-cardiogenic pulmonary edema. Failure may be initiated by pulmonary or extrapulmonary insults (e.g., pneumonia, sepsis, trauma, aspiration) that increase alveolar epithelial endothelial permeability, flood alveoli, and reduce lung compliance. The only treatment proven to improve survival is mechanical ventilation using a 'lung protective strategy' with tidal volume =6 mL/kg predicted body weight. Although mortality can exceed 50%, survivors have a good prognosis for recovery of lung function.

Entities:  

Mesh:

Year:  2010        PMID: 20806836      PMCID: PMC6188356     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  9 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 2.  Advances in mechanical ventilation.

Authors:  M J Tobin
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

3.  Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

Authors:  Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; David Schoenfeld; Herbert P Wiedemann; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

4.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Authors:  Kenneth P Steinberg; Leonard D Hudson; Richard B Goodman; Catherine Lee Hough; Paul N Lanken; Robert Hyzy; B Taylor Thompson; Marek Ancukiewicz
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

Review 5.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

6.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 7.  Epidemiology and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Margaret S Herridge
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

8.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 9.  Transfusion-related acute lung injury: a review.

Authors:  Mark R Looney; Michael A Gropper; Michael A Matthay
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

  9 in total
  47 in total

1.  Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury.

Authors:  Madathilparambil V Suresh; Matthew C Wagner; Gus R Rosania; Kathleen A Stringer; Kyoung Ah Min; Linda Risler; Danny D Shen; George E Georges; Aravind T Reddy; Jaakko Parkkinen; Raju C Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-03       Impact factor: 6.914

2.  Auricularia auricular-judae polysaccharide attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and inflammation.

Authors:  L I Zhuan-Yun; Yao Xue-Ping; Liu Bin; Ha Nizaier Reheman; Gao Yang; Sun Zhan; M A Qi
Journal:  Biomed Rep       Date:  2015-05-26

3.  Age influences inflammatory responses, hemodynamics, and cardiac proteasome activation during acute lung injury.

Authors:  Helena M Linge; Ji Young Lee; Kanta Ochani; Kiyokazu Koga; Nina Kohn; Kaie Ojamaa; Saul R Powell; Edmund J Miller
Journal:  Exp Lung Res       Date:  2015-04-06       Impact factor: 2.459

4.  Regenerative therapy based on miRNA-302 mimics for enhancing host recovery from pneumonia caused by Streptococcus pneumoniae.

Authors:  Yan Wang; Yong Li; Peggy Zhang; Sandy T Baker; Marla R Wolfson; Jeffrey N Weiser; Ying Tian; Hao Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

5.  Arctiin Prevents LPS-Induced Acute Lung Injury via Inhibition of PI3K/AKT Signaling Pathway in Mice.

Authors:  Bo Zhou; Guohu Weng; Zhengxin Huang; Tao Liu; Feiyue Dai
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

6.  Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.

Authors:  Lara Zafrani; Grigoris Gerotziafas; Colleen Byrnes; Xuzhen Hu; Joelle Perez; Charlène Lévi; Sandrine Placier; Emmanuel Letavernier; Asada Leelahavanichkul; Jean-philippe Haymann; Ismail Elalamy; Jeffrey L Miller; Robert A Star; Peter S T Yuen; Laurent Baud
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

7.  Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection.

Authors:  Pooja A Kumar; Yuanyu Hu; Yusuke Yamamoto; Neo Boon Hoe; Tay Seok Wei; Dakai Mu; Yan Sun; Lim Siew Joo; Rania Dagher; Elisabeth M Zielonka; De Yun Wang; Bing Lim; Vincent T Chow; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

8.  Tanshinone II is a potent candidate for treatment of lipopolysaccharide-induced acute lung injury in rat model.

Authors:  Ling Li; Yong-Gang Zhang; Yu-Fei Tan; Jing-Jing Zhao; Hua-Ru Zhang; Bing Zhao
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

9.  Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis.

Authors:  Guangliang Hong; Dong Zheng; Lulu Zhang; Rui Ni; Grace Wang; Guo-Chang Fan; Zhongqiu Lu; Tianqing Peng
Journal:  Free Radic Biol Med       Date:  2018-05-24       Impact factor: 7.376

10.  Effects of JAM-A deficiency or blocking antibodies on neutrophil migration and lung injury in a murine model of ALI.

Authors:  Sowmya P Lakshmi; Aravind T Reddy; Meghna U Naik; Ulhas P Naik; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-17       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.